Praxis Medicines (PRAX): Narxning sotuvga nisbati
Praxis Precision Medicines CNS sohasidagi investitsiyalar yuqori daromadli monopoliyani yaratishi mumkin bo'lgan ventura modeli asosida faoliyat yuritadi. Parametr qiymati 1210.80 ga teng bo'lgan sotuvlarga nisbatan narx tendentsiyasi ushbu xavfni vizuallashtiradi. Epilepsiya davolashga bo'lgan talab iqtisodiy sikllardan qat'i nazar barqaror qolmoqda, patent himoyasi va qat'iy FDA filtrlari esa ushbu nishaga tasodifiy ishtirokchilarning kirishiga to'sqinlik qiladi.
%20Narxning%20daromadga%20nisbati&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_PRAX_-_Praxis-Precision-Medicines_-_Price-to-Revenue-Ratio "Bozor kapitallashuvining daromadga nisbati: Praxis Corp (PRAX) 21.05.2023 - 19.02.2026 uchun | 👁️GURU.Markets👁️")
Praxis Medicines (PRAX) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati Praxis Precision Medicines|PRAX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Praxis Corp|PRAX - Kompaniya qarzlari|Sof aktivlarga qarzlar Praxis Medicines|PRAX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Praxis Precision Medicines|Shoshilinch likvidlik praxismedicines.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
PRAX - Kompaniyaning sof foydasi|Sof foyda prognozi Praxis Precision Medicines|PRAX - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Praxis Precision Medicines Inc|PRAX - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Praxis Medicines|PRAX - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Praxis Precision Medicines|PRAX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi praxismedicines.com|PRAX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Praxis Precision Medicines
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:PRAX, praxismedicines.com
P/S koeffitsiyenti Praxis Precision Medicines (PRAX) kompaniyasining bozor qiymatini uning yillik savdo hajmi bilan nisbatda belgilaydi, bu esa joriy foydadan qat'i nazar, daromadning har bir birligi uchun to'langan premiumni baholash imkonini beradi. Narx-savdo koeffitsiyentidagi o'zgarishlarni tahlil qilish orqali investor kapitalizatsiyaning tor doiradagi CNS dori segmentidagi muvaffaqiyatlarga va epilepsiyaning kam uchraydigan shakllari uchun dori vositalarining tezlashtirilgan tasdiqlanish istiqbollariga sezgirligini aniqlashi mumkin.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC (Regencell Bioscience Ltd) - Narxning sotuvga nisbati|AXSM - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|XENE: P/S multiplikatori|Sotuvga nisbatan narx vikingtherapeutics.com (VKTX)|SUPN (Supernus) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Catalyst Pharma (CPRX)|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Corp|Narxning daromadga nisbati Biohaven Ltd. BHVN|Narx/daromad koeffitsiyenti amylyx.com (AMLX)|Trevi Therapeutics, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Anavex AVXL|CeriBell Corp (CBLL) - Narxning daromadga nisbati|Sotuvga nisbatan narx Prothena Corp (PRTA)|Narxning daromadga nisbati Alector Inc.|Kapitalizatsiya va daromad nisbati ANNX (annexonbio.com)|Kapitalizatsiyaning daromadga nisbati OMER (Omeros Corporation)|NGNE (Neurogene Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati AC Immune Corp ACIU|VYGR - Kapitalizatsiyaning daromadga nisbati|Neumora Therapeutics - P/S multiplikatori|Sotuvga nisbatan narx scilexholding.com|TVGN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati ACOG|CGTX (Cognition Therapeutics, Inc.) - P/S multiplikatori|Inhibikase Pharma (IKT) - Narx/daromad koeffitsiyenti|P/S multiplikatori SAVA|Kapitalizatsiyaning daromadga nisbati assertiotx.com ASRT|P/S multiplikatori COYA (Coya Therapeutics)|Narx/daromad koeffitsiyenti VistaGen Therapeutics, Inc. (VTGN)|OVID - Narxning daromadga nisbati|ABOS (Acumen Pharmaceuticals, Inc) - Kapitalizatsiya va daromad nisbati|CRVO: P/S multiplikatori|Sotuvga nisbatan narx Alterity Therapeutics Limited (ATHE)|Narxning daromadga nisbati Clene Inc|PepGen Corp (PEPG) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|RLMD: Narxning sotuvga nisbati|Narxning daromadga nisbati Annovis Bio, Inc. ANVS|Bozor kapitallashuvining daromadga nisbati GRCE|Firefly Neuroscience - P/S multiplikatori|KLTO - P/S multiplikatori|NRSN (neurosense-tx.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati RVPH|Narxning daromadga nisbati MetaVia Inc.|Kapitalizatsiya va daromad nisbati NRXS (neuraxis.com)|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|Neuphoria Therapeutics - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Minerva NERV|ATHA - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ADXN (addextherapeutics.com)|alzamend.com (ALZN) - Narxning daromadga nisbati|Sotuvga nisbatan narx Cyclerion Therapeutics, Inc. (CYCN)|Narxning daromadga nisbati Protagenic Therapeutics Inc.|Pasithea - Narxning sotuvga nisbati|Narxning daromadga nisbati Cortigent, Inc. (CRGT)|ATXI (avenuetx.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCLI (BrainStorm Cell Therapeutics)|P/S multiplikatori Cara Therapeutics Inc. CARA|CHRO: Kapitalizatsiyaning daromadga nisbati|ELYM (Eliem Therapeutics) - Kapitalizatsiya va daromad nisbati|ITCI: P/S multiplikatori|LBPH - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGen Biotech Inc (NKGN) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati NRBO (NeuroBo)|SAGE (Sage Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN (trevena.com) - Narxning sotuvga nisbati|VIGL - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati WENA (anewmeds.com)|CERE: P/S multiplikatori
